Shea Harrelson is an experienced clinician and entrepreneur with a demonstrated history of working in the medical and biotech industry. After graduating from the Medical University of South Carolina with her Physician Assistant degree, she practiced in the field of Cardiology for nine years. She then joined St. Jude Medical where she specialized in the Cardiac Rhythm Management Division.
Shea began her entrepreneurial career in 2013 with building a national sales commercialization and worked with several start-up companies to bring new diagnostic products to market. While always passionate about the medical field, Shea is specifically driven to develop modalities to help combat the global epidemic of antibiotic resistance, which led her to Vikor Scientific.
Shea manages the internal operations, employees and resources of Vikor. She is responsible for the initial and ongoing development of the diagnostic panels and testing algorithms and the overall planning, implementation, and integration of the company’s strategies.
Scotty Branch has been an executive, entrepreneur and founder for multiple organizations from the corporate pharmaceutical world to the diagnostics and lab industry. Before becoming an entrepreneur, he held multiple positions with large pharmaceutical companies such as Johnson & Johnson, Novartis and Roche. These positions ranged from sales representation to corporate management.
As a Co-Founder of Vikor Scientific, he manages the business relations of Vikor, which includes the management of the Sales Division and Area Vice Presidents, C-Suite relationships with healthcare institutions and commercial partners, payor relations, and other facets of the business growth, including the new WestEdge project.
Bill W. Massey, Ph.D
Chief Scientific Officer
Dr. Massey is a world-renowned neuropharmacologist, pharmacogeneticist, life sciences professional, inventor and entrepreneur. Dr. Massey received his Ph.D. in Pharmacology at the University of Arkansas for Medical Sciences and subsequently an investigator at the Pritzker School of Medicine’s Drug Abuse Research Center at The University of Chicago. Dr. Massey holds long-standing adjunct faculty appointments at the University of Arkansas for Medical Sciences (Associate Professor, Dept. of Pharmacology and Interdisciplinary Toxicology) and the University of Mississippi Medical Center (Clinical Assistant Professor, Dept. of Psychiatry).
Dr. Massey has held leadership positions at Merck, Astra Merck, Quintiles, Scirex, Astra Zeneca, Scientific Commercialization, Litmus Molecular Design, SureGene, and GeneAlign. He has played a leadership role in placing 28 new drugs into human testing and 8 new drugs onto the market. Dr. Massey formerly held the Jack Martin, MD Research Professorship in Psychopharmacology at Vanderbilt University, where he conducted research into the genetics, biological basis and pharmacological treatment of schizophrenia and serious mental illness in collaboration with Dr. Herbert Y. Meltzer. Dr. Massey is currently a Visiting Scholar at the Feinberg School of Medicine’s Dept. of Psychiatry and Human Behavior at Northwestern University where he continues his research collaboration with Dr. Meltzer.
Manish P. Patel, MD, RPh, FACS, FPMRS
Chief Medical Officer
Dr. Patel is a specialist in Urology and Male and Female Genitourinary Reconstructive Surgery in North Carolina and has been in medical practice since 2002. He graduated as Valedictorian and an Alpha Omega Alpha Chair from Wright State University School of Medicine in Dayton, Ohio. Subsequently, he completed his formal Urologic Surgery training at the University of North Carolina Hospital in Chapel Hill, N.C.
Dr. Patel is also an alumnus of Rutgers University College of Pharmacy, where he graduated with high honors and worked thereafter to gain experience in the pharmaceutical research industry as a pharmacist prior to medical school.
In addition to the last 18 years of medical practice, Dr. Patel has authored and co-authored numerous publications, served as a keynote speaker and lecturer for medical seminars globally, and participated in leadership on several boards for new drug and device developments. Dr. Patel has served in the past roles of Chief Medical Officer, Director of Research in Charlotte, N.C. and is a key opinion leader in health care delivery.
Most recently, Dr. Patel has focused his career pathway on understanding and creating innovative uses in genomics and genetics to assist his fellow medical providers in utilizing these advancements to treat patients accurately, rapidly and effectively to improve health care outcomes for patients and hospitals.
Saeed R. Khan, Ph.D
President of Research and Development
Dr. Saeed Khan is a highly talented and accomplished scientist with more than 20 years of experience in Pre-clinical drug development, Anticancer drug design and discovery, Molecular Pharmacology, Medicinal Chemistry, Computer-aided drug design of oncology drugs and Regulatory Science and Regulatory Research and has managed numerous multidisciplinary scientific laboratory projects. He is a proven leader, director, proactive collaborator and is adept at stimulating momentum and building successful teams. He received his Ph.D. in 1997 in Biomedical Science at M.D. Anderson Cancer Center and has served as a Biomedical Scientist at M.D. Anderson. He has also served as a Professor and Director of Drug Discovery and Development Center and a Co- Director of Pharmacology-Analytical Center at Johns Hopkins University of Medicine. He currently serves as a Senior Scientist and Head of the FDA-DOD Shelf life Extension Program of Drug Products at the FDA as well as an adjunct faculty member at Johns Hopkins Medicine.
Robin Prince, PharmD
Director of Pharmacy Services
Dr. Robin Prince is a practicing pharmacist with broad experience in clinical, community, pediatric, geriatric, and long-term care pharmacy. Dr. Prince received a Doctor of Pharmacy from the University of Arkansas for Medical Sciences. Dr. Prince held a clinical internship in long-term care, managing therapeutic regimens and hospital protocols in long-term care facilities. Subsequently she practiced pediatric clinical pharmacy at St. Jude Children’s Research Hospital in Memphis, Tennessee. Dr. Prince has practiced community pharmacy since 1988.
Dr. Prince is passionate about implementing pharmacogenetics and personalized medicine into the mainstream of clinical practice. Her vast experience as a practicing pharmacist gives her practical insight in designing custom personalized medicine solutions that fit into clinical practice.
Director of Finance
Kelly Damiano has over 15 years of progressive experience in management, accounting and finance. Her specific focus has included public accounting and corporate finance in the medical technology and healthcare industries. She received her Master’s Degree in Accounting from the University of South Carolina.
Edward S. Spivey
Director of Commercial Communications
Spider Spivey has over 20 years of experience in the Financial Services, Risk Management and Insurance Industries. He is a tenured Director of Operations and has spent the last five years working with sales teams and diagnostic laboratories across the United States.
Area Vice President, Sales – East
Bryan has over 15 years of experience in the Biotechnology industry with a wide range of experience from start-ups to Fortune 500 companies. His skill set is focused in sales, training, and new product launches, specifically in the area of Gastroenterology.
Area Vice President, Sales – West
Warren has over 25 years of experience in medical device, pharmaceutical and lab sales, including wound management and Long Term Care. Warren is passionate and experienced in selling molecular diagnostics from the ground level to management.
Area Vice President, Sales – Midwest
Jamie has over 10 years of experience in clinical diagnostics across multiple healthcare specialties. As a senior executive, he has been recognized for key success in new market penetration, creating training programs for sales representatives, building sales teams from the ground-up and transforming under-performing territories. He thrives in fast-paced environments for start-up companies.